scRNAseq analysis and FISH validation precisely identified clusters of the growth plate chondrocytes.
To perform scRNAseq of growth plate chondrocytes, we harvested femora and tibiae from a female C57BL/6 mouse at 4 weeks of age during the growth spurt and removed as much soft tissue as possible under a stereomicroscope. The distal femoral epiphysis and proximal tibial epiphysis were then dislodged at the growth plate and the metaphysis was dissected out (Fig. S1a). The dislodged epiphysis and dissected metaphysis were digested to isolate growth plate chondrocytes. Hematopoietic cells and red blood cells were removed by magnetic beads for CD45 and Ter119 antibodies, and the resulting single-cell suspension was subjected to scRNAseq on the 10x Genomics platform. Unsupervised data analysis using the Seurat package provided a uniform manifold approximation and projection (UMAP) with 11 distinct cell clusters based on their gene expression profiles (Fig. 1a). Based on the characteristics of the transcriptomes, these 11 clusters appeared to contain not only chondrocytes, but also other cell types such as osteoblasts, endothelial cells, ligamentous fibroblasts, and mesenchymal progenitor cells (Fig. 1b). To annotate the clusters with the goal of distinguishing growth plate chondrocytes from other cell types, we examined gene expression of marker genes that have been reported to be expressed in a specific cell type, followed by histologic validation by FISH on histological sections of 4-week old mice. Aggrecan (Acan) is a pan marker for chondrogenic cells, including articular chondrocytes (Fig. <link rid="fig1">1</link>c-1, 1c-2), growth plate chondrocytes (Fig. <link rid="fig1">1</link>c-1, 1c-3), and, at a lower expression level, perichondral cells (Fig. <link rid="fig1">1</link>c-1, 1c-4). To distinguish articular chondrocytes from growth plate chondrocytes, we used Prg4 (proteoglycan 4 or lubricin)17–19 and Epyc (epiphycan)20,21. Prg4 is highly expressed in articular chondrocytes and meniscal cells (Fig. <link rid="fig1">1</link>d-1, 1d-2) as well as in ligament cells (Fig. 1d-3), but its expression in growth plate chondrocytes and perichondrial cells is minimal (Fig. 1d-4), consistent with a previous report22. In contrast, Epyc is specifically expressed in growth plate chondrocytes (Fig. <link rid="fig1">1</link>e-1, 1e-3) but not in articular chondrocytes (Fig. 1e-2) or perichondrial cells (Fig. 1e-4). Perichondrial cells specifically express Postn (periostin) (Fig. 1f). They also express relatively low levels of Acan, but higher levels of Col1a1 compared to chondrocytes (Fig. 1g). Notably, they can be distinguished from Col1a1-expressing osteoblasts, which are mainly located in the trabecular and endosteal areas, because they do not express Bglap, a marker for mature osteoblasts23. Consistent with previous reports, a fraction of perichondral/periosteal cells in the outer layer express Ctsk24–26, although to a lesser extent compared to osteoclasts in the trabecular area (Fig. 1h). We also identified a cluster of cells expressing Lepr and Pdgfrb, two markers of bone marrow mesenchymal progenitor cells (MPCs)27–29. FISH confirmed that Lepr+Pdgfrb+ MPCs were mainly located in the trabecular region and not in the growth plate (Fig. 1i). In addition, we observed that these two markers, especially Pdgfrb, are robustly expressed in the perichondrium and periosteum (Fig. 1i), which is consistent with previous observations28,29. With this scRNAseq analysis and FISH validation approach, we were able to annotate the 11 clusters with 5 clusters of growth plate chondrocytes (GP1-5, AcanhighEpyc+Prg4−), articular chondrocytes (AC, AcanhighPrg4+), perichondrial cells (PeriChon, Postn+AcanlowCol1a1+Bglap−Ctsk+Pdgfrb+), ligamentous fibroblasts (LF, Eln+Fn1+Prg4+), osteoblasts (OB, Col1a1+Bglap+), mesenchymal progenitor cells (MPCs, Pdgfrb+Lepr+), and endothelial cells (EC, Pecam1+Emcn+) (Fig. 1b).
Apoe is ubiquitously and specifically expressed in growth plate RCs.
To further analyze growth plate chondrocytes, clusters containing growth plate chondrocytes in Fig. 1a (GP1-5) were selected and re-clustered. The transcriptomic profiles of chondrocytes in different zones within the growth plate were analyzed and the clusters were annotated in a similar approach as in Fig. 1 (Fig. 2a, 2b). FISH confirmed the spatial gene expression of genes representing chondrocytes in each zone. For each gene, we compared the localization in tissue sections with our scRNAseq UMAP side-by-side to validate our annotation (Fig. 2c). Clu (Clusterin)30 and Pthlh (PTHrP)11, two previously reported markers for RCs, were specifically expressed in subsets of RCs in the upper layer of the growth plate (Fig. 2c, RC. Enlarged images for Pthlh are shown in Fig.S2a). Ccnd1 (Cyclin D1), which modulates the transition from G1 to S phase31, was mainly expressed at the boundary between unorganized RCs and column-forming proliferating chondrocytes (Fig. 2c, Mito-C, top), suggesting that Ccnd1 labels chondrocytes entering the cell cycle from the quiescent state. On the other hand, the mitotic gene Mki67, which is maximally expressed in the G2 and M phases32, was specifically expressed in a cluster in the UMAP, but these Mki67-expressing chondrocytes were sparsely distributed in the proliferative zone (Fig. 2c, Mito-C, bottom). C1qtnf3 (CTRP3) was previously identified to be expressed in proliferating chondrocytes in the growth plate33. Consistently, we confirmed that C1qtnf3 was specifically expressed in the columnar chondrocytes such as proliferative and prehypertrophic chondrocytes (Fig. 2c, PC, top). In addition, glucose metabolism is an essential metabolic pathway in growth plate chondrocytes34–36. Pgk1, encoding phosphoglycerate kinase 1, an essential glycolytic enzyme, was found exclusively expressed in columnar chondrocytes (Fig. 2c, PC, bottom). Finally, Ihh (Indian hedgehog) and Col10a1 (Type X collagen) are robustly expressed in the prehypertrophic and hypertrophic chondrocytes, respectively (Fig. 2c, PHC/HC). Therefore, we annotated the clusters as shown in Fig. 2a. Pseudotime analysis of these five clusters also showed that the pseudotime score increased as chondrocytes shifted from RC to HC in the UMAP, which also supports our cluster annotation (Fig. 2d). After identifying the cluster for RCs, we searched for marker genes that were ubiquitously expressed in RCs (minimum percentage of expressing cells in the cluster > 90%) and specifically expressed in RCs (the minimum fold change compared to the other four clusters; logFC > 1). Among the 41 differentially expressed genes meeting these criteria, apolipoprotein E (Apoe) had the highest fold change (logFC = 3.87) and was expressed in the majority of cells in the RC cluster (> 99%) (Fig. 2e). FISH combined with Apoe, C1qtnf3, and Col10a1, confirmed that Apoe was ubiquitously and specifically expressed in the resting zone separated from the PZ/PHZ (C1qtnf3+) and HZ (Col10a1+) (Fig. 2f, Fig.S2b). Immunofluorescence staining with the APOE antibody revealed that APOE was expressed in chondrocytes in the RZ but not in the PZ of the human growth plate, suggesting that apolipoprotein E may be commonly expressed in RCs across species (Fig. 2g).
Apoe-mCherry labels RCs after the formation of the secondary ossification center
To further characterize the Apoe-expressing RCs, we generated Apoe-mCherry reporter mice that express mCherry protein under the control of the endogenous Apoe gene promoter and enhancers (the mCherry-BGHpA vector was inserted after the endogenous ATG start codon in exon 2 of the mouse Apoe gene) (Fig. S3a). This reporter model allows us to visualize the real-time Apoe expression in cells with mCherry to characterize Apoe+ growth plate chondrocytes in vivo and in vitro. First, colocalization of mCherry protein and Apoe mRNA was confirmed by a combination of immunofluorescence and FISH (Fig. S3b), indicating that mCherry expression is concomitant with endogenous Apoe expression. During postnatal skeletal development, mCherry expression was not detected in tibial epiphyseal cartilage at postnatal day 5 (P5), before SOC formation (Fig. 3a). mCherry-expressing chondrocytes began to appear in the tibial RZ after SOC formation at P11 (Fig. 3b). At 4 weeks of age (P28), mCherry+ chondrocytes lined up in the RZ, but were not detected in other zones or in articular cartilage, while some expression was observed in the outer layer of the perichondrium (Fig. 3c. the green, yellow, and blue boxes indicate the growth plate, the articular chondrocytes, and the perichondrium, respectively). In later stages of life, the number of mCherry+ RCs decreases over time (Fig. 3d-g), suggesting that RCs in the growth plate are exhausted after skeletal maturity with aging although some mCherry+ RCs remain in the growth plate at 1 year of age.
mCherry + RCs are slow-cycling chondrocytes.
In contrast to proliferating columnar chondrocytes, "resting" chondrocytes are quiescent with a longer cell cycle37. To determine whether mCherry+ chondrocytes are slow-cycling, we performed an EdU pulse-chase assay. Specifically, we injected EdU into 2-week-old Apoe-mCherry mice for 8 consecutive days and tracked EdU incorporation into growth plate chondrocytes at 1 day, 4 days, and 14 days after the last injection (Fig. 4a). At this growing age, chondrocytes can pass through the growth plate within a few days16. Thus, fast-cycling cells lose the EdU label in a few days after multiple cell divisions, while slow-cycling cells can retain it. One day after the 8-day injections, approximately 60% of proliferative chondrocytes (mCherry−) incorporated EdU, while only 30% of mCherry+ RC had EdU, suggesting that fewer mCherry + RCs entered the cell cycle during the 8 days compared to proliferative chondrocytes. Furthermore, as expected, proliferating columnar cells rapidly lost their EdU labeling down to ~ 30% by day 4 and ~ 6% by day 14 (Fig. 4b-c). In contrast, mCherry + cells took much longer to lose their EdU labeling (~ 30% at day 1, ~ 15% at day 4, and ~ 22% at day 14) (Fig. 4b-c), indicating that mCherry + RCs are slow-cycling compared to proliferative chondrocytes. The slight increase in EdU-positive cells in mCherry + RCs from day 4 to day 14 may be due to cell division of slow cycling RCs within the two-week window, as we observed some EdU-positive nuclei aligning close to each other, suggesting that they have just divided from a single nucleus (Fig. 4c, white arrowheads). These results suggest that our Apoe-mCherry reporter mice temporally and spatially label RCs in the growth plate.
Apoe-mCherry RCs contain self-renewing skeletal stem cells.
After SOC formation, the RZ in the growth plate has been shown to harbor skeletal stem cells that express Pthlh11, Axin212,13, or Foxa214. These skeletal stem cells supply chondrocytes that form columns in the growth plate during linear bone growth. We found that most of the Pthlh-expressing stem cells expressed mCherry (Fig. 5a, ~ 94%), but only ~ 27% of the mCherry-expressing cells were Pthlh positive (Fig. 5a). On the other hand, the percentages of Axin2-expressing cells and Foxa2-expressing cells within mCherry + cells are 4% and 12%, respectively (Fig. S4a), which are much lower than Pthlh+ cells. To gain a holistic understanding of these stem cell populations, we examined the positivity of Apoe, Pthlh, Axin2, and Foxa2 gene expression in the RC cluster of our scRNAseq dataset shown in Fig. 2a. We considered positive cells when the raw count for each gene was greater than 0. Fig.S4b shows that most RCs (> 99%) are Apoe+, while Pthlh+, Axin2+, and Foxa2+ cells represent small subsets of RCs, 18%, 2%, and 4%, respectively. These percentages were slightly lower than what we observed in histology (Fig. 5a, Fig.S4a), possibly due to the different detection sensitivities between RNA sequencing and FISH. However, the proportion of these percentages among Pthlh+, Axin2+, and Foxa2+ cells is similar between scRNAseq analysis and FISH (18%, 2%, 4% in scRNAseq data, 27%, 4%, 12% in FISH, respectively). Interestingly, in these subsets of RCs, over 90% of the cells express only one of Pthlh, Axin2, or Foxa2, and there were no triple positive (Pthlh+Axin2+Foxa2+) cells in the RCs (Fig. S4b), suggesting that these genes label independent subsets of RCs and that skeletal stem cells in RCs are heterogeneous. Importantly, Apoe positivity in these subsets of Pthlh+, Axin2+, and Foxa2+ RCs is 99%, 100%, and 97%, respectively. These results suggest that Apoe is a common marker that spans the heterogeneous subsets of skeletal stem cells in RCs.
Previous studies have identified a panel of mouse skeletal stem cell surface markers for flow cytometrical analysis38. We therefore examined the expression of these surface markers on mCherry+ RCs. Following our gating scheme to enrich singlet cells, we removed dead cells and hematopoietic/endothelial cells labeled with CD45, Tie2, and Ter119. In mCherry+ cells of the remaining population, we found that approximately half of the mCherry+ RCs were multipotent cells38, of which ~ 18% were self-renewing mouse skeletal stem cells (SSC, CD45−Tie2−CD51+Thy−6C3−CD105−CD200+), ~ 29.3% were pre-bone, cartilage and stromal progenitors (pre-BCSP, CD45−Tie2−CD51+Thy−6C3−CD105−CD200−), and ~ 2.8% were bone, cartilage and stromal progenitors (BCSP, CD45−Tie2−CD51+Thy−6C3−CD105+) (Fig. 5b). These results demonstrated that mCherry+ RCs contain skeletal stem cells as well as skeletal progenitor cells, further indicating the heterogeneity of RCs.
To functionally validate that Apoe-mCherry cells contain skeletal stem cells, we sorted mCherry+ cells for in vitro and in vivo differentiation experiments. In addition to RCs, mCherry+ cells were also detected in the bone marrow (Fig. 3). Our scRNAseq analysis of bone marrow cells showed that Apoe was also expressed in endothelial cells, macrophages, and MPCs (data not shown). Therefore, to remove mCherry+ cells from the bone marrow and enrich mCherry+ RCs, in addition to CD31 and CD45, markers for endothelial cells and hematopoietic cells including macrophages, we utilized CD73, which has been reported as a RC marker9. To confirm the specificity of CD73, we separately harvested cells from the growth plate and bone marrow of Apoe-mCherry mice and examined the positivity of CD73 in mCherry+ cells. The majority of mCherry+ cells isolated from the growth plate were positive for CD73, whereas those from the bone marrow were predominantly negative (Fig. S5). Therefore, we sorted mCherry+ RCs as CD31−CD45−Ter119−CD73+mCherry+ cells and cultured them under osteogenic, chondrogenic, and adipogenic differentiation conditions (Fig. 5c). The sorted mCherry+ RCs were able to differentiate into osteoblasts and chondrocytes as demonstrated by alizarin red and alcian blue staining (Fig. 5c). However, these mCherry+ RCs exhibited limited adipogenic differentiation potential (Fig. 5c), which is consistent with previous findings regarding the non-adipogenic skeletal stem cells38. We then performed a colony-forming assay to determine whether mCherry+ RCs contain more stem cells than mCherry− cells. When seeded at a low cell density (100 cells/cm2), mCherry+ RCs formed a significantly higher number of colonies with cell numbers > 50 compared to mCherry− cells in vitro (Fig. 5d). Finally, we transplanted mCherry+ RCs into kidney capsules of wild-type mice and harvested 4 weeks after the transplantation. mCherry+ cells formed bone nodules with the bone marrow cavity (Fig. 5e-g), demonstrating their in vivo ability to form bone and the bone marrow niche as stromal progenitors.